Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Credit Suisse Upgrades Next To Neutral

Mon, 16th Sep 2019 09:24

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

CREDIT SUISSE RAISES NEXT TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 6000 (5000) PENCE

----------

BERENBERG CUTS ROYAL DUTCH SHELL B PRICE TARGET TO 2750 (2900) PENCE - 'HOLD'

----------

BERENBERG CUTS BP PRICE TARGET TO 600 (620) PENCE - 'BUY'

----------

JPMORGAN CUTS PRUDENTIAL PRICE TARGET TO 1627 (1761) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS PHOENIX GROUP PRICE TARGET TO 846 (857) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS LEGAL & GENERAL PRICE TARGET TO 269 (285) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS HISCOX PRICE TARGET TO 1750 (1800) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES AVIVA PRICE TARGET TO 498 (484) PENCE - 'OVERWEIGHT'

----------

UBS RAISES WM MORRISON SUPERMARKETS PRICE TARGET TO 250 (245) PENCE - 'BUY'

----------

RBC CUTS AB FOODS PRICE TARGET TO 2600 (2900) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS RAISES SEGRO PRICE TARGET TO 807 (786) PENCE - 'BUY'

----------

GOLDMAN CUTS LAND SECURITIES PRICE TARGET TO 761 (807) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS BRITISH LAND PRICE TARGET TO 526 (566) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

GOLDMAN RAISES SHAFTESBURY PRICE TARGET TO 735 (714) PENCE - 'SELL'

----------

GOLDMAN CUTS GREAT PORTLAND PRICE TARGET TO 583 (585) PENCE - 'SELL'

----------

GOLDMAN RAISES DERWENT LONDON PRICE TARGET TO 3163 (3095) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES BIG YELLOW GROUP PRICE TARGET TO 1042 (1037) PENCE - 'NEUTRAL'

----------

GOLDMAN RESUMES CINEWORLD GROUP WITH 'BUY' - TARGET 315 PENCE

----------

GOLDMAN RAISES HAMMERSON TO 'BUY' ('NEUTRAL') - TARGET 303 (288) PENCE

----------

JPMORGAN CUTS LANCASHIRE HOLDINGS PRICE TARGET TO 645 (650) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS BEAZLEY PRICE TARGET TO 630 (665) PENCE - 'OVERWEIGHT'

----------

RBC CUTS WEIR GROUP PRICE TARGET TO 1900 (2000) PENCE - 'OUTPERFORM'

----------

JEFFERIES CUTS GO-AHEAD GROUP TO 'HOLD' ('BUY') - TARGET 2160 (2290) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

GOLDMAN RAISES SECURE INCOME PRICE TARGET TO 547 (447) PENCE - 'BUY'

----------

JPMORGAN CUTS JUST GROUP PRICE TARGET TO 54 (78) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS ABCAM PRICE TARGET TO 1134 (1144) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS MCBRIDE PRICE TARGET TO 55 (60) PENCE - 'HOLD'

----------

More News
25 Jul 2016 15:15

Abcam describes 'another successful year' ahead of results

(ShareCast News) - Life science research tools supplier Abcam posted a trading update for the year to 30 June on Monday, ahead of the publication of its financial results, due 12 September. The AIM-traded firm described "another successful year" and claimed to have achieved above market revenue grow

Read more
20 Jun 2016 15:35

Abcam announces Wood as new finance chief

(ShareCast News) - Life science research tools firm Abcam announced on Monday the appointment of Gavin Wood as its chief financial officer. The AIM-traded firm said Wood, who is the former executive vice president and CFO of Affymetrix, is to join the company on 18 July and succeed Jeff Iliffe after

Read more
20 Jun 2016 06:40

Abcam Appoints Gavin Wood As New Chief Financial Officer

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
14 Mar 2016 09:33

BROKER RATINGS SUMMARY: HSBC And Merrill Lynch Downgrade Admiral

Read more
10 Mar 2016 16:13

Dividends Calendar - Week Ahead

Read more
7 Mar 2016 14:30

Abcam shares sink on news of lower earnings

(ShareCast News) - Abcam tried to paint its interim results as strong on Monday, with the biotechnology company making increased investment for the future, though the market did not agree in afternoon trading. The AIM-traded firm saw revenue rise 17.2% on a constant currency basis and 18% on a repor

Read more
7 Mar 2016 07:51

Abcam Confident In Meeting Full-Year Targets As COO To Retire

Read more
29 Feb 2016 16:08

Earnings, Trading Statements Calendar - Week Ahead

Read more
26 Jan 2016 09:43

BROKER RATINGS SUMMARY: UBS Upgrades RBS To Buy From Neutral

Read more
25 Jan 2016 10:36

Avacta Poaches Abcam's Cotrel For Chief Commercial Officer Role

Read more
25 Jan 2016 07:56

Abcam Expects Revenue Growth Of 17% For First Half

Read more
5 Jan 2016 09:43

BROKER RATINGS SUMMARY: S&P CapIQ Cuts Next To Buy From Strong Buy

Read more
27 Nov 2015 15:44

Dividends Calendar - Week Ahead

Read more
11 Nov 2015 16:40

DIRECTOR DEALINGS: Abcam CEO Buys GBP19,343 Of Stock After AxioMx Deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.